Clinical Trials · NCT02288273
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- AstraZeneca
- Enrollment
- 239
- Start date
- Dec 2014
- Locations
- 29 sites, United States
- Primary endpoint
- Change in 24-hour Mean Weighted Glucose